|
Variable
| |
All Procedures
|
CABG
|
AVR/MVR/MVrpr
|
CABG + Valve
|
|---|
| | |
n=4270
|
n=3095
|
n=696
|
n=479
|
|---|
| | |
(%)
|
(%)
|
(%)
|
(%)
|
|---|
|
MACE*
| |
15.7
|
13.0
|
14.0
|
32.0
|
|
Mortality
| |
4.2
|
3.3
|
3.3
|
11.5
|
|
Acute renal failure
| |
6.5
|
5.5
|
5.5
|
14.0
|
|
Any stroke
| |
2.9
|
2.3
|
2.4
|
7.3
|
| |
Transient (<24 h)
|
1.7
|
0.9
|
1.2
|
3.1
|
| |
Permanent
|
1.7
|
1.4
|
1.3
|
4.2
|
|
Infection
| |
8.0
|
7.1
|
6.3
|
16.1
|
| |
Deep sternal Wound infection
|
1.1
|
1.0
|
0.1
|
2.9
|
| |
Sepsis
|
2.8
|
2.4
|
1.9
|
7.3
|
| |
Pneumonia
|
6.5
|
5.7
|
5.3
|
13.6
|
- *MACE—Major Adverse Cardiac Event defined as in-hospital death, stroke (persisting at discharge or transient), acute renal failure (new post-operative renal failure or acute on chronic (>50% increase from baseline creatinine)), or infection (sepsis, pneumonia, or deep sternal wound infection).
